Skip Nav Destination
Issues
Clinical Care/Education/Nutrition
Exercise Training, Without Weight Loss, Increases Insulin Sensitivity and Postheparin Plasma Lipase Activity in Previously Sedentary Adults
Glen E. Duncan, PHD, RCEPSM; Michael G. Perri, PHD; Douglas W. Theriaque, MS; Alan D. Hutson, PHD; Robert H. Eckel, MD; Peter W. Stacpoole, PHD, MD
Diabetes Care March 2003, Vol.26, 557-562. doi:https://doi.org/10.2337/diacare.26.3.557
Quality of Care for Diabetic Patients in a Large Urban Public Hospital
Diabetes Care March 2003, Vol.26, 563-568. doi:https://doi.org/10.2337/diacare.26.3.563
Comparative Effects of Irbesartan on Ambulatory and Office Blood Pressure: A substudy of ambulatory blood pressure from the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study
Kasper Rossing, MD; Per K. Christensen, MD; Steen Andersen, MD; Peter Hovind, MD; Henrik Post Hansen, MD; Hans-Henrik Parving, PROF, DMSC, MD
Diabetes Care March 2003, Vol.26, 569-574. doi:https://doi.org/10.2337/diacare.26.3.569
A Comparison of the Prevalence of the Metabolic Syndrome Using Two Proposed Definitions
Diabetes Care March 2003, Vol.26, 575-581. doi:https://doi.org/10.2337/diacare.26.3.575
Clinical Performance of CGMS in Type 1 Diabetic Patients Treated by Continuous Subcutaneous Insulin Infusion Using Insulin Analogs
Bruno Guerci, MD, PHD; Michèle Floriot, MD; Philip Böhme, MD; Danielle Durain, RN; Muriel Benichou, MD; Stéphanie Jellimann, MD; Pierre Drouin, MD
Diabetes Care March 2003, Vol.26, 582-589. doi:https://doi.org/10.2337/diacare.26.3.582
Insulin Detemir Is Associated With More Predictable Glycemic Control and Reduced Risk of Hypoglycemia Than NPH Insulin in Patients With Type 1 Diabetes on a Basal-Bolus Regimen With Premeal Insulin Aspart
Philippe Vague, MD, PHD; Jean-Louis Selam, MD; Svein Skeie, MD; Ivo De Leeuw; Jan W.F. Elte, MD, PHD; Hanne Haahr, PHD; Allan Kristensen, MSC; Eberhard Draeger, PHD
Diabetes Care March 2003, Vol.26, 590-596. doi:https://doi.org/10.2337/diacare.26.3.590
Lifestyle Modification to Improve Blood Pressure Control in Individuals With Diabetes: Is physician advice effective?
Diabetes Care March 2003, Vol.26, 602-607. doi:https://doi.org/10.2337/diacare.26.3.602
The Effect of Alcohol Intake on Insulin Sensitivity in Men: A randomized controlled trial
Renate R. Zilkens, MPH; Valerie Burke, MD; Gerald Watts, MD, PHD; Laurence J. Beilin, MD; Ian B. Puddey, MD
Diabetes Care March 2003, Vol.26, 608-612. doi:https://doi.org/10.2337/diacare.26.3.608
Fatty Acid Composition of Serum Lipid Fractions in Type 2 Diabetic Patients With Microalbuminuria
Magda S. Perassolo, BC; Jussara C. Almeida, RD; Ronivan L. Prá, BC; Vanessa D. Mello, RD; Ana L. Maia, MD; Cileide C. Moulin, RD; Joíza L. Camargo, MSC; Themis Zelmanovitz, MD; Mirela J. Azevedo, MD; Jorge L. Gross, MD
Diabetes Care March 2003, Vol.26, 613-618. doi:https://doi.org/10.2337/diacare.26.3.613
Dietary Fat Predicts Coronary Heart Disease Events in Subjects With Type 2 Diabetes
Diabetes Care March 2003, Vol.26, 619-624. doi:https://doi.org/10.2337/diacare.26.3.619
Amino Acid Ingestion Strongly Enhances Insulin Secretion in Patients With Long-Term Type 2 Diabetes
Luc J.C. van Loon, PHD; Margriet Kruijshoop, MSC; Paul P.C.A. Menheere, PHD; Anton J.M. Wagenmakers, PHD; Wim H.M. Saris, MD, PHD; Hans A. Keizer, MD, PHD
Diabetes Care March 2003, Vol.26, 625-630. doi:https://doi.org/10.2337/diacare.26.3.625
Epidemiology/Health Services/Psychosocial Research
The PedsQL™ in Type 1 and Type 2 Diabetes: Reliability and validity of the Pediatric Quality of Life Inventory™ Generic Core Scales and Type 1 Diabetes Module
James W. Varni, PHD; Tasha M. Burwinkle, MA; Jenifer R. Jacobs, PHD; Michael Gottschalk, MD, PHD; Francine Kaufman, MD; Kenneth L. Jones, MD
Diabetes Care March 2003, Vol.26, 631-637. doi:https://doi.org/10.2337/diacare.26.3.631
Prospective Analysis of Mortality, Morbidity, and Risk Factors in Elderly Diabetic Subjects: Nagano Study
Masafumi Katakura, MD; Motoji Naka, MD; Teruki Kondo, MD; Nakako Nishii, MD; Mitsuhisa Komatsu, MD; Yoshihiko Sato, MD; Keishi Yamauchi, MD; Kunihide Hiramatsu, MD; Mitsuru Ikeda, MD; Toru Aizawa, MD; Kiyoshi Hashizume, MD
Diabetes Care March 2003, Vol.26, 638-644. doi:https://doi.org/10.2337/diacare.26.3.638
Visceral Adiposity and the Risk of Impaired Glucose Tolerance: A prospective study among Japanese Americans
Tomoshige Hayashi, MD, PHD; Edward J. Boyko, MD, MPH; Donna L. Leonetti, PHD; Marguerite J. McNeely, MD, MPH; Laura Newell-Morris, PHD; Steven E. Kahn, MB, CHB; Wilfred Y. Fujimoto, MD
Diabetes Care March 2003, Vol.26, 650-655. doi:https://doi.org/10.2337/diacare.26.3.650
The Association Between Impaired Glucose Tolerance and Birth Weight Among Black and White Women in Central North Carolina
Tina M. Saldana, PHD, RD; Anna Maria Siega-Riz, PHD; Linda S. Adair, PHD; David A. Savitz, PHD; John M. Thorp, Jr., MD
Diabetes Care March 2003, Vol.26, 656-661. doi:https://doi.org/10.2337/diacare.26.3.656
Hypoglycemia Prevalence in Prepubertal Children With Type 1 Diabetes on Standard Insulin Regimen: Use of Continuous Glucose Monitoring System
Rakesh Amin, MBCLB, MRCP; Karen Ross, BSC; Carlo L. Acerini, MD; Julie A. Edge, MD; Justin Warner, MD; David B. Dunger, FRCPL
Diabetes Care March 2003, Vol.26, 662-667. doi:https://doi.org/10.2337/diacare.26.3.662
Community-Based Screening for Diabetes in Michigan
Bahman P. Tabaei, MPH; Ray Burke, MA; Ann Constance, MA, RD, CDE; Jean Hare, RN MPA, CDE; Glenda May-Aldrich, MA, RD, CDE; Sandra A. Parker, RD, CDE; Ann Scott, RN MSN; Anne Stys, RN BSN, CDE; Jean Chickering, RN MSN; William H. Herman, MD, MPH
Diabetes Care March 2003, Vol.26, 668-670. doi:https://doi.org/10.2337/diacare.26.3.668
Incidence of Type 1 Diabetes in Lithuanians Aged 0–39 Years Varies by the Urban-Rural Setting, and the Time Change Differs for Men and Women During 1991–2000
Auste Pundziute-Lyckå, MD; Brone Urbonaite, MD, PHD; Rytas Ostrauskas, MD, PHD; Rimas Zalinkevicius, MD, PHD; Gisela G. Dahlquist, MD, PHD
Diabetes Care March 2003, Vol.26, 671-676. doi:https://doi.org/10.2337/diacare.26.3.671
The Impact of Smoking on Inhaled Insulin
Anders Himmelmann, MD, PHD; Johan Jendle, MD, PHD; Anders Mellén, MD; Astrid H. Petersen, MSC; Ulf L. Dahl, MSC; Per Wollmer, MD, PHD
Diabetes Care March 2003, Vol.26, 677-682. doi:https://doi.org/10.2337/diacare.26.3.677
Losartan Reduces the Costs Associated With Diabetic End-Stage Renal Disease: The RENAAL study economic evaluation
William H. Herman, MD, MPH; Shahnaz Shahinfar, MD; George W. Carides, PHD; Erik J. Dasbach, PHD; William C. Gerth, MBA; Charles M. Alexander, MD; John R. Cook, PHD; William F. Keane, MD; Barry M. Brenner, MD; For the RENAAL Investigators
Diabetes Care March 2003, Vol.26, 683-687. doi:https://doi.org/10.2337/diacare.26.3.683
Is the Current Definition for Diabetes Relevant to Mortality Risk From All Causes and Cardiovascular and Noncardiovascular Diseases?
Diabetes Care March 2003, Vol.26, 688-696. doi:https://doi.org/10.2337/diacare.26.3.688
Clinical Diagnosis of Diabetic Polyneuropathy With the Diabetic Neuropathy Symptom and Diabetic Neuropathy Examination Scores
Jan-Willem G. Meijer, MD, PHD; Eelke Bosma, MD; Johan D. Lefrandt, MD; Thera P. Links, MD, PHD; Andries J. Smit, MD, PHD; Roy E. Stewart; Johannes H. van der Hoeven, MD, PHD; Klaas Hoogenberg, MD, PHD
Diabetes Care March 2003, Vol.26, 697-701. doi:https://doi.org/10.2337/diacare.26.3.697
Diabetes and Sleep Disturbances: Findings from the Sleep Heart Health Study
Helaine E. Resnick, PHD, MPH; Susan Redline, MD, MPH; Eyal Shahar, MD, MPH; Adele Gilpin, PHD, JD; Anne Newman, MD; Robert Walter, MD; Gordon A. Ewy, MD; Barbara V. Howard, PHD; Naresh M. Punjabi, MD, PHD
Diabetes Care March 2003, Vol.26, 702-709. doi:https://doi.org/10.2337/diacare.26.3.702
Are Spouses of Patients With Type 2 Diabetes at Increased Risk of Developing Diabetes?
Diabetes Care March 2003, Vol.26, 710-712. doi:https://doi.org/10.2337/diacare.26.3.710
The Confidence in Diabetes Self-Care Scale: Psychometric properties of a new measure of diabetes-specific self-efficacy in Dutch and U.S. patients with type 1 diabetes
Nicole C.W. van der Ven, MSC; Katie Weinger, EDD; Joyce Yi, BA; Frans Pouwer, PHD; Herman Adèr, PHD; Henk M. van der Ploeg, PHD; Frank J. Snoek, PHD
Diabetes Care March 2003, Vol.26, 713-718. doi:https://doi.org/10.2337/diacare.26.3.713
Work Stress and Low Sense of Coherence Is Associated With Type 2 Diabetes in Middle-Aged Swedish Women
Emilie E. Agardh, RN, MPH; Anders Ahlbom, PHD; Tomas Andersson, BSC; Suad Efendic, MD, PHD; Valdemar Grill, MD, PHD; Johan Hallqvist, MD, PHD; Anders Norman, MD; Claes-Göran Östenson, MD, PHD
Diabetes Care March 2003, Vol.26, 719-724. doi:https://doi.org/10.2337/diacare.26.3.719
The Diabetes Risk Score: A practical tool to predict type 2 diabetes risk
Diabetes Care March 2003, Vol.26, 725-731. doi:https://doi.org/10.2337/diacare.26.3.725
Changes in Diabetes Self-Care Behaviors Make a Difference in Glycemic Control: The Diabetes Stages of Change (DiSC) study
Helen Jones, RN, MSN; Lynn Edwards, PDT, MHSA; T. Michael Vallis, PHD; Laurie Ruggiero, PHD; Susan R. Rossi, RN, PHD; Joseph S. Rossi, PHD; Geoffrey Greene, RD, PHD; James O. Prochaska, PHD; Bernard Zinman, MD
Diabetes Care March 2003, Vol.26, 732-737. doi:https://doi.org/10.2337/diacare.26.3.732
How Well Do Patients’ Assessments of Their Diabetes Self-Management Correlate With Actual Glycemic Control and Receipt of Recommended Diabetes Services?
Michele Heisler, MD, MPA; Dylan M. Smith, PHD; Rodney A. Hayward, MD; Sarah L. Krein, PHD; Eve A. Kerr, MD, MPH
Diabetes Care March 2003, Vol.26, 738-743. doi:https://doi.org/10.2337/diacare.26.3.738
Unadjusted and Adjusted Prevalence of Diagnosed Depression in Type 2 Diabetes
Diabetes Care March 2003, Vol.26, 744-749. doi:https://doi.org/10.2337/diacare.26.3.744
Emerging Treatments and Technologies
A Controlled Trial of Web-Based Diabetes Disease Management : The MGH Diabetes Primary Care Improvement Project
James B. Meigs, MD, MPH; Enrico Cagliero, MD; Anil Dubey, MD; Patricia Murphy-Sheehy, MPH; Catharyn Gildesgame, MBA; Henry Chueh, MD; Michael J. Barry, MD; Daniel E. Singer, MD; David M. Nathan, MD
Diabetes Care March 2003, Vol.26, 750-757. doi:https://doi.org/10.2337/diacare.26.3.750
Comparison of a Clinical Model, the Oral Glucose Tolerance Test, and Fasting Glucose for Prediction of Type 2 Diabetes Risk in Japanese Americans
Marguerite J. McNeely, MD; Edward J. Boyko, MD; Donna L. Leonetti, PHD; Steven E. Kahn, MB, CHB; Wilfred Y. Fujimoto, MD
Diabetes Care March 2003, Vol.26, 758-763. doi:https://doi.org/10.2337/diacare.26.3.758
Inhaled Insulin Using the AERx Insulin Diabetes Management System in Healthy and Asthmatic Subjects
Robert R. Henry, MD; Sunder R.D. Mudaliar, MD; William C. Howland III, MD; Neelima Chu, MD; Dennis Kim, MD; Bob An, PHD; Rickey R. Reinhardt, MD, PHD
Diabetes Care March 2003, Vol.26, 764-769. doi:https://doi.org/10.2337/diacare.26.3.764
The Sensory Symptoms of Diabetic Polyneuropathy Are Improved With α-Lipoic Acid: The SYDNEY Trial
The SYDNEY Trial Authors, for the SYDNEY Trial Study Group:; Alexander S. Ametov, MD; Alexei Barinov, MD; Peter J. Dyck, MD; Robert Hermann, MD; Natalia Kozlova, MD; William J. Litchy, MD; Phillip A. Low, MD; Detlef Nehrdich, DIPL STAT; Maria Novosadova, MD; Peter C. O’Brien, PHD; Miroslav Reljanovic, MD; Rustem Samigullin, MD; Klemens Schuette, BSC; Igor Strokov, MD; Hans J. Tritschler, PHD; Klaus Wessel, PHD; Nikolai Yakhno, MD; Dan Ziegler, MD
Diabetes Care March 2003, Vol.26, 770-776. doi:https://doi.org/10.2337/diacare.26.3.770
Vardenafil, a New Phosphodiesterase Type 5 Inhibitor, in the Treatment of Erectile Dysfunction in Men With Diabetes: A multicenter double-blind placebo-controlled fixed-dose study
Irwin Goldstein, MD; Jay M. Young, MD; Jerome Fischer, MD; Keith Bangerter, PHD; Thomas Segerson, MD; Terry Taylor, MD; The Vardenafil Diabetes Study Group
Diabetes Care March 2003, Vol.26, 777-783. doi:https://doi.org/10.2337/diacare.26.3.777
Differential Effects of Acute and Extended Infusions of Glucagon-Like Peptide-1 on First- and Second-Phase Insulin Secretion in Diabetic and Nondiabetic Humans
Shaista Quddusi, MD; Torsten P. Vahl, MD; Kevin Hanson, MD; Ronald L. Prigeon, MD; David A. D’Alessio, MD
Diabetes Care March 2003, Vol.26, 791-798. doi:https://doi.org/10.2337/diacare.26.3.791
Randomized Cross-Over Trial of Insulin Glargine Plus Lispro or NPH Insulin Plus Regular Human Insulin in Adolescents With Type 1 Diabetes on Intensive Insulin Regimens
Nuala P. Murphy, MRCPI; Suzanne M. Keane, MRCPCH; Ken K. Ong, MRCPCH; Martha Ford-Adams, MRCPCH; Julie A. Edge, MD; Carlo L. Acerini, MD; David B. Dunger, MD
Diabetes Care March 2003, Vol.26, 799-804. doi:https://doi.org/10.2337/diacare.26.3.799
Emerging Treatment and Technologies
Pramlintide as an Adjunct to Insulin Therapy Improves Long-Term Glycemic and Weight Control in Patients With Type 2 Diabetes: A 1-year randomized controlled trial
Priscilla A. Hollander, MD; Philip Levy, MD; Mark S. Fineman, BS; David G. Maggs, MD; Larry Z. Shen, PHD; Susan A. Strobel, PHD; Christian Weyer, MD; Orville G. Kolterman, MD
Diabetes Care March 2003, Vol.26, 784-790. doi:https://doi.org/10.2337/diacare.26.3.784
Pathophysiology/Complications
Insulin Sensitivity and the Risk of Incident Hypertension: Insights from the Insulin Resistance Atherosclerosis Study
Diabetes Care March 2003, Vol.26, 805-809. doi:https://doi.org/10.2337/diacare.26.3.805
Serum Lipoproteins in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Intervention and Complications Cohort: Associations with gender and glycemia
Alicia J. Jenkins, MD; Timothy J. Lyons, MD; Deyi Zheng, MD, PHD; James D. Otvos, PHD; Daniel T. Lackland, PHD; Daniel McGee, PHD; W. Timothy Garvey, MD; Richard L. Klein, PHD; The DCCT/EDIC Research Group
Diabetes Care March 2003, Vol.26, 810-818. doi:https://doi.org/10.2337/diacare.26.3.810
First-Trimester C-Reactive Protein and Subsequent Gestational Diabetes
Myles Wolf, MD, MMSC; Laura Sandler, BS; Karen Hsu, BA; Karen Vossen-Smirnakis, MD, PHD; Jeffrey L. Ecker, MD; Ravi Thadhani, MD,MPH
Diabetes Care March 2003, Vol.26, 819-824. doi:https://doi.org/10.2337/diacare.26.3.819
β-Cell Function and the Development of Diabetes-Related Complications in the Diabetes Control and Complications Trial
Diabetes Care March 2003, Vol.26, 832-836. doi:https://doi.org/10.2337/diacare.26.3.832
Effect of Glucagon-Like Peptide 1 (7-36 Amide) on Insulin-Mediated Glucose Uptake in Patients With Type 1 Diabetes
Graydon S. Meneilly, MD; Christopher H.S. McIntosh, PHD; Raymond A. Pederson, PHD; Joel F. Habener, MD; Mario R.W. Ehlers, PHD; Josephine M. Egan, MD; Dariush Elahi, PHD
Diabetes Care March 2003, Vol.26, 837-842. doi:https://doi.org/10.2337/diacare.26.3.837
Association of the CTLA-4 Gene 49 A/G Polymorphism With Type 1 Diabetes and Autoimmune Thyroid Disease in Japanese Children
Mie Mochizuki, MD; Shin Amemiya, MD; Kisho Kobayashi, MD; Koji Kobayashi, MD; Yoshie Shimura, MD; Toshihide Ishihara, MD; Yoshiko Nakagomi, MD; Kazumichi Onigata, MD; Shinya Tamai, MD; Akira Kasuga, MD; Shinpei Nanazawa, MD
Diabetes Care March 2003, Vol.26, 843-847. doi:https://doi.org/10.2337/diacare.26.3.843
Impact of Incident Diabetes and Incident Nonfatal Cardiovascular Disease on 18-Year Mortality: The Multiple Risk Factor Intervention Trial experience
Lynn E. Eberly, PHD; Jerome D. Cohen, MD; Ronald Prineas, MD, PHD; Lingfeng Yang, MS; For The Multiple Risk Factor Intervention Trial Research Group
Diabetes Care March 2003, Vol.26, 848-854. doi:https://doi.org/10.2337/diacare.26.3.848
Development of Congestive Heart Failure in Type 2 Diabetic Patients With Microalbuminuria or Proteinuria: Observations from the DIABHYCAR (type 2 DIABetes, Hypertension, CArdiovascular Events and Ramipril) study
Laurent Vaur, MD; Pascal Gueret, MD; Michel Lievre, PHD; Sylvie Chabaud, PHD; Philippe Passa, MD; For the DIABHYCAR Study Group
Diabetes Care March 2003, Vol.26, 855-860. doi:https://doi.org/10.2337/diacare.26.3.855
Insulin Resistance, the Metabolic Syndrome, and Risk of Incident Cardiovascular Disease in Nondiabetic American Indians: The Strong Heart Study
Helaine E. Resnick, PHD, MPH; Kristina Jones, MPH; Giacomo Ruotolo, MD, PHD; Arvind K. Jain, MS; Jeffrey Henderson, MD; Weiquan Lu, MD; Barbara V. Howard, PHD
Diabetes Care March 2003, Vol.26, 861-867. doi:https://doi.org/10.2337/diacare.26.3.861
Insulin Secretion and Insulin Sensitivity Pattern Is Different in Isolated Impaired Glucose Tolerance and Impaired Fasting Glucose: The Risk Factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes Study
Markolf Hanefeld, MD, PHD; Carsta Koehler, PHD; Katja Fuecker, DIPL CHEM; Elena Henkel, MD; Frank Schaper, MD; Theodora Temelkova-Kurktschiev, MD, PHD
Diabetes Care March 2003, Vol.26, 868-874. doi:https://doi.org/10.2337/diacare.26.3.868
Soluble Tumor Necrosis Factor-α Receptors in Young Obese Subjects With Normal and Impaired Glucose Tolerance
Stella Dzienis-Straczkowska, MD; Marek Straczkowski, MD; Malgorzata Szelachowska, MD; Agnieszka Stepien, PHD; Irina Kowalska, MD; Ida Kinalska, MD
Diabetes Care March 2003, Vol.26, 875-880. doi:https://doi.org/10.2337/diacare.26.3.875
Safety and Efficacy of Repaglinide in Type 2 Diabetic Patients With and Without Impaired Renal Function
Diabetes Care March 2003, Vol.26, 886-891. doi:https://doi.org/10.2337/diacare.26.3.886
RANTES Promoter Genotype Is Associated With Diabetic Nephropathy in Type 2 Diabetic Subjects
Kunihiro Nakajima, MD; Yasushi Tanaka, MD; Takashi Nomiyama, MD; Takeshi Ogihara, MD; Fuki Ikeda, MD; Rei Kanno, MD; Noseki Iwashita, MD; Ken Sakai, MD; Hirotaka Watada, MD; Tomio Onuma, MD; Ryuzo Kawamori, MD
Diabetes Care March 2003, Vol.26, 892-898. doi:https://doi.org/10.2337/diacare.26.3.892
Type 2 Diabetic Individuals Have Impaired Leg Blood Flow Responses to Exercise: Role of endothelium-dependent vasodilation
Bronwyn A. Kingwell, PHD; Melissa Formosa, BSC; Michael Muhlmann, MBBS, FRACP; Scott J. Bradley, BSC(HONS); Glenn K. McConell, PHD
Diabetes Care March 2003, Vol.26, 899-904. doi:https://doi.org/10.2337/diacare.26.3.899
Value of Coronary Artery Calcium Scanning by Computed Tomography for Predicting Coronary Heart Disease in Diabetic Subjects
Wenchun Qu, MS; Thuy T. Le, MD; Stanley P. Azen, PHD; Min Xiang, MS; Nathan D. Wong, PHD; Terence M. Doherty, BA; Robert C. Detrano, MD, PHD
Diabetes Care March 2003, Vol.26, 905-910. doi:https://doi.org/10.2337/diacare.26.3.905
Smoking and Progression of Diabetic Nephropathy in Type 1 Diabetes
Diabetes Care March 2003, Vol.26, 911-916. doi:https://doi.org/10.2337/diacare.26.3.911
Reviews/Commentaries/Position Statements
American Association of Clinical Endocrinologists (AACE) Consensus Conference on the Insulin Resistance Syndrome: 25–26 August 2002, Washington, DC
Diabetes Care March 2003, Vol.26, 933-939. doi:https://doi.org/10.2337/diacare.26.3.933
Editorial
Do We Need the Oral Glucose Tolerance Test to Identify Future Cases of Type 2 Diabetes?
Diabetes Care March 2003, Vol.26, 940-941. doi:https://doi.org/10.2337/diacare.26.3.940
Electronic Medical Records and Diabetes Care Improvement: Are we waiting for Godot?
Diabetes Care March 2003, Vol.26, 942-943. doi:https://doi.org/10.2337/diacare.26.3.942
Point-Counterpoint
Point: Yes, It Is Necessary to Rely Entirely on Glycemic Values for the Insulin Treatment of All Gestational Diabetic Women
Diabetes Care March 2003, Vol.26, 946-947. doi:https://doi.org/10.2337/diacare.26.3.946
Counterpoint: Glucose Monitoring in Gestational Diabetes: Lots of heat, not much light
Diabetes Care March 2003, Vol.26, 948-949. doi:https://doi.org/10.2337/diacare.26.3.948
Letters: Observations
U-Shaped Association Between White Blood Cell Count and Fasting Plasma Glucose Level
Koji Tamakoshi, MD, PHD; Hiroshi Yatsuya, MD, PHD; Takaaki Kondo, MD, PHD; Yoko Hori, PHD; Huiming Zhang, MD; Miyuki Ishikawa, ME; Chiyoe Murata, MPH; Rei Otsuka, BSC; ShanKuan Zhu, MD, PHD; Hideaki Toyoshima, MD, PHD
Diabetes Care March 2003, Vol.26, 950. doi:https://doi.org/10.2337/diacare.26.3.950
Impact of an Intramural Competition on Outcome of Diabetes Care
Diabetes Care March 2003, Vol.26, 950-951. doi:https://doi.org/10.2337/diacare.26.3.950-a
Heteroplasmic Mitochondrial DNA 3310 Mutation in NADH Dehydrogenase Subunit 1 Associated With Type 2 Diabetes, Hypertrophic Cardiomyopathy, and Mental Retardation in a Single Patient
Yukiko Hattori, MD; Kazuo Nakajima, MD; Takayuki Eizawa, MD; Takashi Ehara, MD; Masamichi Koyama, MD; Tetsuya Hirai, PHD; Youji Fukuda, PHD; Moritoshi Kinoshita, PHD
Diabetes Care March 2003, Vol.26, 952-953. doi:https://doi.org/10.2337/diacare.26.3.952
A New Case Of Lipoatrophy With Lispro Insulin In Insulin Pump Therapy: Is there any insulin preparation free of complications?
Diabetes Care March 2003, Vol.26, 953-954. doi:https://doi.org/10.2337/diacare.26.3.953
Intensive Insulin Treatment and QT-interval
Stefanos Foussas, PHD; Alexander Stefanidis, MD; Andreas Melidonis, PHD; Symeon Tournis, MD; Panayiotis Michail, PHD; Theodosios Dosios, PHD; Panayiotis Asimacopoulos, PHD
Diabetes Care March 2003, Vol.26, 954-955. doi:https://doi.org/10.2337/diacare.26.3.954
Pitfalls in the Laboratory Diagnosis of Diabetic Ketoacidosis in Gitelman’s Syndrome
Diabetes Care March 2003, Vol.26, 955. doi:https://doi.org/10.2337/diacare.26.3.955
Austronesian-Speaking People in Papua New Guinea have Susceptibility to Obesity and Type 2 Diabetes
Motoyoshi Sakaue, MD, PHD; Yoko Fuke, BS; Toshie Katsuyama, BS; Masato Kawabata, MD; Hiroshi Taniguchi, MD, PHD
Diabetes Care March 2003, Vol.26, 955-956. doi:https://doi.org/10.2337/diacare.26.3.955-a
Metformin-Induced Hemolytic Anemia in a Patient With Glucose-6- Phosphate Dehydrogenase Deficiency
Diabetes Care March 2003, Vol.26, 956-957. doi:https://doi.org/10.2337/diacare.26.3.956
No Delay in Glucose Change at Antecubital Skin in Hypoglycemia of Normal Subjects
Diabetes Care March 2003, Vol.26, 957-958. doi:https://doi.org/10.2337/diacare.26.3.957
Pregnancy Complicated by Diabetic Ketoacidosis: Maternal and fetal outcomes
Michael B. Schneider, MD; Guillermo E. Umpierrez, MD; Risa D. Ramsey, PHD; William C. Mabie, MD; Kelly A. Bennett, MD
Diabetes Care March 2003, Vol.26, 958-959. doi:https://doi.org/10.2337/diacare.26.3.958
Cost Effectiveness of the Direct Measurement of 3-β-Hydroxybutyrate in the Management of Diabetic Ketoacidosis in Children
Diabetes Care March 2003, Vol.26, 959. doi:https://doi.org/10.2337/diacare.26.3.959
Prediction of Wound Radius Reductions and Healing Times in Neuropathic Diabetic Foot Ulcers
Diabetes Care March 2003, Vol.26, 959-960. doi:https://doi.org/10.2337/diacare.26.3.959-a
Evidence for Associated Cutaneous Microangiopathy in Diabetic Patients With Neuropathic Foot Ulceration
Nathalie Chabbert-Buffet, MD; Claude LeDevehat, MD; Taraneh Khodabandhelou, PHD; Eric Allaire, MD; Jean Pierre Gaitz, MD; Laurent Tribout, MD; Nathalie Abdoucheli-Baudot, MD; Michel Vayssairat, MD
Diabetes Care March 2003, Vol.26, 960-961. doi:https://doi.org/10.2337/diacare.26.3.960
Letters: Comments and Responses
Coronary Artery Disease and Carotid Artery Intima-Media Thickness in Japanese Type 2 Diabetic Patients
Diabetes Care March 2003, Vol.26, 961. doi:https://doi.org/10.2337/diacare.26.3.961
Response to Ostberg and Hurel
Diabetes Care March 2003, Vol.26, 961-962. doi:https://doi.org/10.2337/diacare.26.3.961-a
Acute and Prolonged Effects of Sildenafil on Brachial Artery Flow-Mediated Dilatation in Type 2 Diabetes
Diabetes Care March 2003, Vol.26, 962-963. doi:https://doi.org/10.2337/diacare.26.3.962
Response to Gómez-Ulla et al.
Enrique Soto-Pedre, MD, MSC; María Concepción Hernáez-Ortega, MD, PHD; José Antonio Vázquez, MD, PHD
Diabetes Care March 2003, Vol.26, 963-964. doi:https://doi.org/10.2337/diacare.26.3.963-a
Response to Soto-Pedre et al.
Francisco Gómez-Ulla, MD; Maria I. Fernandez, MD; Francisco Gonzalez, MD; Pablo Rey, PHD; Marta Rodríguez, MD; Maria J. Rodriguez-Cid, MD; Felipe F. Casanueva, MD; Maria A. Tome, MD; Javier Garcia-Tobio, MD; Francisco Gude, MD
Diabetes Care March 2003, Vol.26, 964-965. doi:https://doi.org/10.2337/diacare.26.3.964
Response to Merin and Reeves
Francisco Gómez-Ulla, MD; Maria I. Fernandez, MD; Francisco Gonzalez, MD; Pablo Rey, PHD; Marta Rodríguez, MD; Maria J. Rodriguez-Cid, MD; Felipe F. Casanueva, MD; Maria A. Tome, MD; Javier Garcia-Tobio, MD; Francisco Gude, MD
Diabetes Care March 2003, Vol.26, 966-967. doi:https://doi.org/10.2337/diacare.26.3.966
Response to Schade: To pump or not to pump?
Diabetes Care March 2003, Vol.26, 967. doi:https://doi.org/10.2337/diacare.26.3.967
Response to Cersosimo
Diabetes Care March 2003, Vol.26, 967-968. doi:https://doi.org/10.2337/diacare.26.3.967-a
